KoBioLabs, Inc
Research KoBioLabs, Inc (348150.KQ) on Bullrun: market cap KRW 54.57B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker348150.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 54.57B
- Financial periodQ2 2026
- RevenueKRW 21.81B
- Net income-KRW 3.80B
- Free cash flow-KRW 800.92M
- Gross margin74.6%
Valuation Snapshot
latest market cap is KRW 54.57B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 54.57B | n/a | n/a | n/a |
Dividend history
About KoBioLabs, Inc
KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and brain diseases. The company was founded in 2014 and is based in Seoul, South Korea.
Related stock research
Other Healthcare stocks
ORIENT BIO Inc. (002630.KS)
GC Corp. (005250.KS)
Pharmicell Co., Ltd. (005690.KS)
Kanaph Therapeutics Inc. (0082N0.KQ)
Samik Pharmaceutical Company LTD. (014950.KQ)
HLB Co., Ltd. (028300)
Mgen Solutions Co., Ltd. (032790.KQ)
Daesung Microbiological Labs. Co., Ltd. (036480.KQ)
Seoulin Bioscience Co.,Ltd. (038070.KQ)
Hyundai Bioscience Co., Ltd. (048410.KQ)
iNtRON Biotechnology, Inc. (048530.KQ)
Synergy Innovation Co., Ltd. (048870.KQ)
Frequently asked questions
What is KoBioLabs, Inc's market cap?
KoBioLabs, Inc's market capitalization is KRW 54.57B.
What does KoBioLabs, Inc do?
KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and brain diseases. The company was founded in 2014 and is based in Seoul, South Korea.